INBIOGEN Co., Ltd. (KRX:101140)
South Korea · Delayed Price · Currency is KRW 9,430.00
+330.00 (3.63%)
At close: Mar 12, 2026
INBIOGEN Market Cap
INBIOGEN has a market cap or net worth of 97.75 billion as of March 13, 2026. Its market cap has increased by 114.69% in one year.
Market Cap
97.75B
Enterprise Value
97.47B
Revenue
7.80B
Ranking
n/a
PE Ratio
3.74
Stock Price
9,430.00
Market Cap Chart
Since August 14, 2008, INBIOGEN's market cap has decreased from 218.39B to 97.75B, a decrease of -55.24%. That is a compound annual growth rate of -4.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 94.16B | -10.10% |
| Dec 30, 2025 | 104.74B | 103.00% |
| Dec 29, 2022 | 51.60B | -72.31% |
| Dec 30, 2021 | 186.34B | -26.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JS Corporation | 353.13B |
| Hwaseung Enterprise | 293.56B |
| Au Brandz Co.,Ltd | 280.37B |
| BAIKSAN Co,. | 276.42B |
| HWASEUNG Industries | 161.25B |
| Samyang Tongsang | 151.54B |
| 09WOMEN | 129.13B |
| The Nature Holdings | 107.20B |